We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
73 hedge funds and large institutions have $121M invested in Sorrento Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
540% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 5
213% more capital invested
Capital invested by funds: $38.6M → $121M (+$82.4M)
127% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 11
59% more funds holding
Funds holding: 46 → 73 (+27)
38% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $1.67M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
73
Holders Change
+27
Holders Change %
+58.7%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
32
Increased
25
Reduced
11
Closed
5
Calls
$1.04M
Puts
$1.67M
Net Calls
-$626K
Net Calls Change
-$704K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$36.5M |
| 2 |
BlackRock
New York
|
+$8.67M |
| 3 |
Renaissance Technologies
New York
|
+$6.38M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.96M |
| 5 |
D.E. Shaw & Co
New York
|
+$4.93M |
